Ling F W
Department of Obstetrics and Gynecology, University of Tennessee, Memphis 38103, USA.
J Clin Psychiatry. 2000;61 Suppl 12:9-16.
The author's aim is to aid primary care physicians and obstetrician-gynecologists in correctly diagnosing and treating premenstrual dysphoric disorder (PMDD). The symptoms fluctuate markedly, but their timing is key. PMDD patients experience symptoms only during the luteal phase and will have a symptom-free interval after the menstrual flow and before ovulation. The author discusses self-report instruments, which are valuable tools for diagnosis when combined with the ICD-10 criteria for premenstrual syndrome (PMS) or the DSM-IV criteria for PMDD and the ruling out of medical and psychiatric conditions, such as diabetes, hypothyroidism, major depression, and dysthymia, that cause similar symptoms. Treatment strategies ranging from nonpharmacologic approaches such as dietary modification and aerobic exercise to pharmacologic interventions such as antidepressants, anxiolytics, and agents to suppress ovulation are examined.
作者的目的是帮助初级保健医生和妇产科医生正确诊断和治疗经前烦躁障碍（PMDD）。症状波动明显，但其发作时间是关键。PMDD患者仅在黄体期出现症状，月经来潮后至排卵前无症状期。作者讨论了自我报告工具，这些工具与国际疾病分类第10版（ICD - 10）经前综合征（PMS）标准或精神疾病诊断与统计手册第4版（DSM - IV）PMDD标准相结合，并排除导致类似症状的内科和精神疾病（如糖尿病、甲状腺功能减退、重度抑郁症和心境恶劣）时，是诊断的宝贵工具。研究了从饮食调整和有氧运动等非药物方法到抗抑郁药、抗焦虑药和抑制排卵药物等药物干预的治疗策略。
